Literature DB >> 19664640

A trade-off between neutrality and adaptability limits the optimization of viral quasispecies.

Jacobo Aguirre1, Ester Lázaro, Susanna C Manrubia.   

Abstract

Theoretical studies of quasispecies usually focus on two properties of those populations at the mutation-selection equilibrium, namely asymptotic growth rate and population diversity. It has been postulated that, as a consequence of the high error rate of quasispecies replication, an increase of neutrality facilitates population optimization by reducing the amount of mutations with a deleterious effect on fitness. In this study we analyse how the optimization of equilibrium properties is affected when a quasispecies evolves in an environment perturbed through frequent bottleneck events. By means of a simple model we demonstrate that high neutrality may be detrimental when the population has to overcome repeated reductions in the population size, and that the property to be optimized in this situation is the time required to regenerate the quasispecies, i.e. its adaptability. In the scenario described, neutrality and adaptability cannot be simultaneously optimized. When fitness is equated with long-term survivability, high neutrality is the appropriate strategy in constant environments, while populations evolving in fluctuating environments are fitter when their neutrality is low, such that they can respond faster to perturbations. Our results might be relevant to better comprehend how a minority virus could displace the circulating quasispecies, a fact observed in natural infections and essential in viral evolution.

Entities:  

Mesh:

Year:  2009        PMID: 19664640     DOI: 10.1016/j.jtbi.2009.07.034

Source DB:  PubMed          Journal:  J Theor Biol        ISSN: 0022-5193            Impact factor:   2.691


  9 in total

1.  Pathways to extinction: beyond the error threshold.

Authors:  Susanna C Manrubia; Esteban Domingo; Ester Lázaro
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2010-06-27       Impact factor: 6.237

2.  Phenotypic effect of mutations in evolving populations of RNA molecules.

Authors:  Michael Stich; Ester Lázaro; Susanna C Manrubia
Journal:  BMC Evol Biol       Date:  2010-02-17       Impact factor: 3.260

3.  Identification and characterization of influenza variants resistant to a viral endonuclease inhibitor.

Authors:  Min-Suk Song; Gyanendra Kumar; William R Shadrick; Wei Zhou; Trushar Jeevan; Zhenmei Li; P Jake Slavish; Thomas P Fabrizio; Sun-Woo Yoon; Thomas R Webb; Richard J Webby; Stephen W White
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-14       Impact factor: 11.205

4.  Congruent evolution of fitness and genetic robustness in vesicular stomatitis virus.

Authors:  Isabel S Novella; John B Presloid; Cameron Beech; Claus O Wilke
Journal:  J Virol       Date:  2013-02-13       Impact factor: 5.103

5.  Severe hindrance of viral infection propagation in spatially extended hosts.

Authors:  José A Capitán; José A Cuesta; Susanna C Manrubia; Jacobo Aguirre
Journal:  PLoS One       Date:  2011-08-23       Impact factor: 3.240

6.  Variability in mutational fitness effects prevents full lethal transitions in large quasispecies populations.

Authors:  Josep Sardanyés; Carles Simó; Regina Martínez; Ricard V Solé; Santiago F Elena
Journal:  Sci Rep       Date:  2014-04-09       Impact factor: 4.379

7.  The advantage of arriving first: characteristic times in finite size populations of error-prone replicators.

Authors:  Arturo Marín; Héctor Tejero; Juan Carlos Nuño; Francisco Montero
Journal:  PLoS One       Date:  2013-12-23       Impact factor: 3.240

8.  Differences in adaptive dynamics determine the success of virus variants that propagate together.

Authors:  María Arribas; Jacobo Aguirre; Susanna Manrubia; Ester Lázaro
Journal:  Virus Evol       Date:  2018-01-09

9.  Antigenic diversification is correlated with increased thermostability in a mammalian virus.

Authors:  John B Presloid; Tasneem F Mohammad; Adam S Lauring; Isabel S Novella
Journal:  Virology       Date:  2016-06-23       Impact factor: 3.616

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.